Demographic, clinical, and laboratory characteristics of the 47 serum samples tested by both SARS-CoV-2 spike protein ELISA (spike ELISA) and Abbott ArchitectTM IgG assay (Architect) with at least one
Supplementary Material 3. Sequencing results per sample (A) and experimental group (B). Number of reads prior to (i.e., 'raw') and following (i.e., 'combined') paired-ends (PE) merge, quality filterin
